Cargando…
Etodolac improves collagen induced rheumatoid arthritis in rats by inhibiting synovial inflammation, fibrosis and hyperplasia
Synovial hyperplasia is the main cause of chronic rheumatoid arthritis (RA), but the mechanism of synovial hyperplasia is still unclear. Etodolac (ETD) is a selective COX-2 inhibitor for relieving pain and stiffness in RA, but the disease modifying effect is still lack of evidence. Proteomics method...
Autores principales: | Feng, Qin, Xia, Wenkai, Wang, Shenglan, Dai, Guoxin, Jiao, Weimei, Guo, Na, Li, Honghua, Zhang, Guimin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607370/ https://www.ncbi.nlm.nih.gov/pubmed/35006449 http://dx.doi.org/10.1186/s43556-021-00052-1 |
Ejemplares similares
-
Pathogenetic roles of Synoviolin in synovial hyperplasia of rheumatoid arthritis
por: Yamasaki, S, et al.
Publicado: (2003) -
Curcumin alleviates rheumatoid arthritis-induced inflammation and synovial hyperplasia by targeting mTOR pathway in rats
por: Dai, Qiaoding, et al.
Publicado: (2018) -
Etodolac transdermal cubosomes for the treatment of rheumatoid arthritis: ex vivo permeation and in vivo pharmacokinetic studies
por: Salah, Salwa, et al.
Publicado: (2017) -
Sigesbeckia glabrescens Makino extract attenuated the collagen-induced arthritis through inhibiting the synovial hyperplasia and inflammation
por: Ma, Qiu Shuo, et al.
Publicado: (2020) -
Lysyl oxidase is involved in synovial hyperplasia and angiogenesis in rats with collagen-induced arthritis
por: Wang, Fan, et al.
Publicado: (2017)